1.
|
B CariouC Le MayP CostetClinical aspects
of
PCSK9Atherosclerosis216258265201110.1016/j.atherosclerosis.2011.04.01821596380
|
2.
|
KN MaxwellRE SoccioEM DuncanE SehayekJL
BreslowNovel putative SREBP and LXR target genes identified by
microarray analysis in liver of cholesterol-fed miceJ Lipid
Res4421092119200310.1194/jlr.M300203-JLR20012897189
|
3.
|
NG SeidahS BenjannetL WickhamThe secretory
proprotein convertase neural apoptosis-regulated convertase 1
(NARC-1): liver regeneration and neuronal differentiationProc Natl
Acad Sci USA100928933200310.1073/pnas.0335507100
|
4.
|
T YamamotoC LuRO RyanA two-step binding
model of PCSK9 interaction with the low density lipoprotein
receptorJ Biol
Chem28654645470201110.1074/jbc.M110.19904221149300
|
5.
|
J DavignonG DubucNG SeidahThe influence of
PCSK9 polymorphisms on serum low-density lipoprotein cholesterol
and risk of atherosclerosisCurr Atheroscler
Rep12308315201010.1007/s11883-010-0123-620623344
|
6.
|
SA MousaviKE BergeTP LerenThe unique role
of proprotein convertase subtilisin/kexin 9 in cholesterol
homeostasisJ Intern
Med266507519200910.1111/j.1365-2796.2009.02167.x19930098
|
7.
|
AJ MarianPCSK9 as a therapeutic target in
atherosclerosisCurr Atheroscler
Rep12151154201010.1007/s11883-010-0099-220425252
|
8.
|
CJ DuffNM HooperPCSK9: an emerging target
for treatment of hypercholesterolemiaExpert Opin Ther
Targets15157168201110.1517/14728222.2011.54748021204732
|
9.
|
S PoirierA PratE MarcinkiewiczImplication
of the proprotein convertase NARC-1/PCSK9 in the development of the
nervous systemJ
Neurochem98838850200610.1111/j.1471-4159.2006.03928.x16893422
|
10.
|
KR FeingoldAH MoserJK ShigenagaSM PatzekC
GrunfeldInflammation stimulates the expression of PCSK9Biochem
Biophys Res
Commun374341344200810.1016/j.bbrc.2008.07.02318638454
|
11.
|
H LanL PangMM SmithProprotein convertase
subtilisin/kexin type 9 (PCSK9) affects gene expression pathways
beyond cholesterol metabolism in liver cellsJ Cell
Physiol224273281201020333646
|
12.
|
R RossAtherosclerosis is an inflammatory
diseaseAm Heart
J138S419S420199910.1016/S0002-8703(99)70266-810539839
|
13.
|
G RodriguezN MagoF RosaRole of
inflammation in atherogenesisInvest Clin501091292009
|
14.
|
P SahaB ModaraiJ HumphriesK MattockM
WalthamKG BurnandA SmithThe monocyte/macrophage as a therapeutic
target in atherosclerosisCurr Opin
Pharmacol9109118200910.1016/j.coph.2008.12.01719230773
|
15.
|
CY WuZH TangL JiangXF LiZS JiangLS
LiuPCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via
Bcl/Bax-caspase9-caspase3 pathwayMol Cell
Biochem359347358201210.1007/s11010-011-1028-621847580
|
16.
|
ZH TangLS LiuJ PengQ YangHT LiuZS
JiangInvestigation of NARC-1 protein expression in atherosclerotic
lesion of New Zealand rabbitChin J Arterioscler1735372009(in
Chinese)
|
17.
|
P LibbyY OkamotoVZ RochaE
FolcoInflammation in atherosclerosis: transition from theory to
practiceCirc J74213220201020065609
|
18.
|
K YinC TangInflammation, lipid metabolism
dysfunction, and hypertension: Active research fields in
atherosclerosis-related cardiovascular disease in ChinaSci China
Life Sci54976979201110.1007/s11427-011-4225-3
|
19.
|
KL MaXZ RuanSH PowisY ChenJF MoorheadZ
VargheseInflammatory stress exacerbates lipid accumulation in
hepatic cells and fatty livers of apolipoprotein E knockout
miceHepatology48770781200810.1002/hep.2242318752326
|
20.
|
K YinDF LiaoCK TangATP-binding membrane
cassette transporter A1 (ABCA1): a possible link between
inflammation and reverse cholesterol transportMol
Med16438449201020485864
|
21.
|
K YinX DengZC MoTristetraprolin-dependent
post-transcriptional regulation of inflammatory cytokine mRNA
expression by apolipoprotein A–I: role of ATP-binding membrane
cassette transporter A1 and signal transducer and activator of
transcription 3J Biol Chem2861383413845201121339300
|
22.
|
A RoubtsovaMN MunkondaZ AwanCirculating
proprotein convertase subtilisin/kexin 9 (PCSK9) regulates VLDLR
protein and triglyceride accumulation in visceral adipose
tissueArterioscler Thromb Vasc
Biol31785791201110.1161/ATVBAHA.110.220988
|
23.
|
OL HollaJ CameronK TvetenTB StromKE
BergeJK LaerdahlTP LerenRole of the C-terminal domain of PCSK9 in
degradation of the LDL receptorsJ Lipid
Res5217871794201110.1194/jlr.M01809321771976
|
24.
|
AK SoutarUnexpected roles for PCSK9 in
lipid metabolismCurr Opin
Lipidol22192196201110.1097/MOL.0b013e32834622b521494143
|
25.
|
TS FisherP Lo SurdoS PanditEffects of pH
and low density lipoprotein (LDL) on PCSK9-dependent LDL receptor
regulationJ Biol
Chem2822050220512200710.1074/jbc.M70163420017493938
|
26.
|
D CunninghamDE DanleyKF
GeogheganStructural and biophysical studies of PCSK9 and its
mutants linked to familial hypercholesterolemiaNat Struct Mol
Biol14413419200710.1038/nsmb123517435765
|
27.
|
DW ZhangTA LagaceR GarutiZ ZhaoM
McDonaldJD HortonJC CohenHH HobbsBinding of proprotein convertase
subtilisin/kexin type 9 to epidermal growth factor-like repeat A of
low density lipoprotein receptor decreases receptor recycling and
increases degradationJ Biol
Chem2821860218612200710.1074/jbc.M702027200
|
28.
|
J CameronOL HollaT RanheimMA KulsethKE
BergeTP LerenEffect of mutations in the PCSK9 gene on the cell
surface LDL receptorsHum Mol
Genet1515511558200610.1093/hmg/ddl07716571601
|
29.
|
M MbikayF SiroisJ MaynePCSK9-deficient
mice exhibit impaired glucose tolerance and pancreatic islet
abnormalitiesFEBS
Lett584701706201010.1016/j.febslet.2009.12.01820026049
|
30.
|
C LanghiC Le MayV GmyrPCSK9 is expressed
in pancreatic delta-cells and does not alter insulin
secretionBiochem Biophys Res
Commun39012881293200910.1016/j.bbrc.2009.10.13819878649
|
31.
|
K De BosscherBW VandenG HaegemanThe
interplay between the glucocorticoid receptor and nuclear
factor-kappaB or activator protein-1: molecular mechanisms for gene
repressionEndocr Rev244885222003
|
32.
|
G GloireS Legrand-PoelsJ PietteNF-kappaB
activation by reactive oxygen species: fifteen years laterBiochem
Pharmacol7214931505200616723122
|
33.
|
MP de WintherE KantersG KraalMH
HofkerNuclear factor kappaB signaling in atherogenesisArterioscler
Thromb Vasc Biol25904914200515731497
|
34.
|
C XieJ KangME FergusonS NagarajanTM
BadgerX WuBlueberries reduce pro-inflammatory cytokine TNF-α and
IL-6 production in mouse macrophages by inhibiting NF-κB activation
and the MAPK pathwayMol Nutr Food Res55158715912011
|
35.
|
L LeiH LiF YanY LiY XiaoPorphyromonas
gingivalis lipopolysaccharide alters atherosclerotic-related
gene expression in oxidized low-density-lipoprotein-induced
macrophages and foam cellsJ Periodontal
Res46427437201110.1111/j.1600-0765.2011.01356.x
|